Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men
- PMID: 19841381
- PMCID: PMC2764414
- DOI: 10.1212/WNL.0b013e3181bd10e7
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men
Abstract
Background: The purpose of this study was to evaluate the relationship between cognitive performance, risk factors for cardiovascular and cerebrovascular disease (CVD), and HIV infection in the era of highly active antiretroviral therapy.
Methods: We evaluated the cognitive functions of men enrolled in the cardiovascular disease substudy of the Multicenter AIDS Cohort Study who were aged > or =40 years, with no self-reported history of heart disease or cerebrovascular disease. Results from comprehensive neuropsychological evaluations were used to construct composite scores of psychomotor speed and memory performance. Subclinical CVD was assessed by measuring coronary artery calcium and carotid artery intima-media thickness (IMT), as well as laboratory measures, including total cholesterol, fasting glucose, glycosylated hemoglobin, glomerular filtration rate (estimated), and standardized blood pressure and heart rate measures.
Results: After accounting for education, depression, and race, carotid IMT and glomerular filtration rate were significantly associated with psychomotor speed, whereas IMT was associated with memory test performance. HIV serostatus was not significantly associated with poorer cognitive test performance. However, among the HIV-infected individuals, the presence of detectable HIV RNA in plasma was linked to lower memory performance.
Conclusions: These findings suggest that HIV infection may not be the most important predictor of cognitive performance among older gay and bisexual men in the post-highly active antiretroviral therapy era, at least among those with access to medical care and to appropriate medications. Medical factors associated with normal aging are significantly associated with performance on neuropsychological tests, and good clinical management of these factors both in HIV-infected individuals and those at risk for infection may have beneficial effects in the short term and could reduce the risk of subsequent cognitive decline.
References
-
- Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med 2005;118:890–898. - PubMed
-
- Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992;42:1472–1476. - PubMed
-
- Chiesi A, Vella S, Dally LG, et al. Epidemiology of AIDS dementia complex in Europe. J Acquir Immun Defic Syndr 1996;11:39–44. - PubMed
-
- Stoff DM. Mental health research in HIV/AIDS and aging: problems and prospects. AIDS 2004;18(suppl 1):3–10. - PubMed
-
- Valcour V, Shikuma C, Shiramizu B, et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaiian Aging with HIV Cohort. J Neuroimmunol 2004;157:197–202. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01-AI-35042/AI/NIAID NIH HHS/United States
- U01-AI-37613/AI/NIAID NIH HHS/United States
- 5-M01-RR-00052/RR/NCRR NIH HHS/United States
- U01-AI-35041/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- U01-AI-35040/AI/NIAID NIH HHS/United States
- U01-AI-37984/AI/NIAID NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI037984/AI/NIAID NIH HHS/United States
- U01-AI-35043/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical